JS, D., M, C., G, L., G, M., F, T., PR, P., . . . A, N. (2021). Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model. Nature communications, 12(1), 1735. https://doi.org/10.1038/s41467-021-21992-w
Chicago Style (17th ed.) CitationJS, Driouich, et al. "Favipiravir Antiviral Efficacy Against SARS-CoV-2 in a Hamster Model." Nature Communications 12, no. 1 (2021): 1735. https://doi.org/10.1038/s41467-021-21992-w.
MLA (9th ed.) CitationJS, Driouich, et al. "Favipiravir Antiviral Efficacy Against SARS-CoV-2 in a Hamster Model." Nature Communications, vol. 12, no. 1, 2021, p. 1735, https://doi.org/10.1038/s41467-021-21992-w.
Warning: These citations may not always be 100% accurate.